By Katherine Hamilton
Arcus Biosciences named former Amgen executive Richard Markus as its chief medical officer.
The biopharmaceutical company, which is focused on cancer treatments, said Tuesday that Markus is scheduled to begin the role on Jan. 31.
Markus previously worked at biotechnology company Amgen for 13 years in various roles, including vice president of global development. Most recently, he founded an oncology-focused drug company called Dantari, where he served as chief executive.
Markus succeeds Dimitry Nuyten, who is set to depart the company to pursue other opportunities. In 2023, Nuyten made a base salary of $562,000 and a total compensation of $3.69 billion, according to a filing from the company.
Write to Katherine Hamilton at katherine.hamilton@wsj.com
(END) Dow Jones Newswires
January 21, 2025 16:43 ET (21:43 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。